Increased non‐AIDS mortality among persons with AIDS‐defining events after antiretroviral therapy initiation
Open Access
- 15 January 2018
- journal article
- research article
- Published by Wiley in Journal of the International AIDS Society
- Vol. 21 (1)
Abstract
Introduction: HIV‐1 infection leads to chronic inflammation and to an increased risk of non‐AIDS mortality. Our objective was to determine whether AIDS‐defining events (ADEs) were associated with increased overall and cause‐specific non‐AIDS related mortality after antiretroviral therapy (ART) initiation.Methods: We included HIV treatment‐naïve adults from the Antiretroviral Therapy Cohort Collaboration (ART‐CC) who initiated ART from 1996 to 2014. Causes of death were assigned using the Coding Causes of Death in HIV (CoDe) protocol. The adjusted hazard ratio (aHR) for overall and cause‐specific non‐AIDS mortality among those with an ADE (all ADEs, tuberculosis (TB), Pneumocystis jiroveci pneumonia (PJP), and non‐Hodgkin's lymphoma (NHL)) compared to those without an ADE was estimated using a marginal structural model.Results: The adjusted hazard of overall non‐AIDS mortality was higher among those with any ADE compared to those without any ADE (aHR 2.21, 95% confidence interval (CI) 2.00 to 2.43). The adjusted hazard of each of the cause‐specific non‐AIDS related deaths were higher among those with any ADE compared to those without, except metabolic deaths (malignancy aHR 2.59 (95% CI 2.13 to 3.14), accident/suicide/overdose aHR 1.37 (95% CI 1.05 to 1.79), cardiovascular aHR 1.95 (95% CI 1.54 to 2.48), infection aHR (95% CI 1.68 to 2.81), hepatic aHR 2.09 (95% CI 1.61 to 2.72), respiratory aHR 4.28 (95% CI 2.67 to 6.88), renal aHR 5.81 (95% CI 2.69 to 12.56) and central nervous aHR 1.53 (95% CI 1.18 to 5.44)). The risk of overall and cause‐specific non‐AIDS mortality differed depending on the specific ADE of interest (TB, PJP, NHL).Conclusions: In this large multi‐centre cohort collaboration with standardized assignment of causes of death, non‐AIDS mortality was twice as high among patients with an ADE compared to without an ADE. However, non‐AIDS related mortality after an ADE depended on the ADE of interest. Although there may be unmeasured confounders, these findings suggest that a common pathway may be independently driving both ADEs and NADE mortality. While prevention of ADEs may reduce subsequent death due to NADEs following ART initiation, modification of risk factors for NADE mortality remains important after ADE survival.Keywords
Funding Information
- Medical Research Council (MR/J002380/1)
- Department for International Development
- National Institutes of Health (K08 AI104352, NIH P30 AI 54999, NIH P30 AI110527, NIH K 24 AI065298)
- Agence Nationale de Recherches sur le Sida et les Hépatites Virales
- Augustinus Fonden
- Seventh Framework Programme (FP7/2007‐2013)
- National Institute for Health Research (NF‐SI‐0611‐10168)
This publication has 40 references indexed in Scilit:
- Impact of Cigarette Smoking and Smoking Cessation on Life Expectancy Among People With HIV: A US-Based Modeling StudyThe Journal of Infectious Diseases, 2016
- Tuberculosis and cardiovascular disease: linking the epidemicsTropical Diseases, Travel Medicine and Vaccines, 2015
- Tuberculosis increases the subsequent risk of acute coronary syndrome: a nationwide population-based cohort studyThe International Journal of Tuberculosis and Lung Disease, 2014
- Cohort Profile: Antiretroviral Therapy Cohort Collaboration (ART-CC)International Journal of Epidemiology, 2013
- Morbidity and Aging in HIV-Infected Persons: The Swiss HIV Cohort StudyClinical Infectious Diseases, 2011
- Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D studyAIDS, 2010
- Rate of Comorbidities Not Related to HIV Infection or AIDS among HIV‐Infected Patients, by CD4 Cell Count and HAART Use StatusClinical Infectious Diseases, 2008
- Class of Antiretroviral Drugs and the Risk of Myocardial InfarctionNew England Journal of Medicine, 2007
- Trends in Causes of Death among Persons with Acquired Immunodeficiency Syndrome in the Era of Highly Active Antiretroviral Therapy, San Francisco, 1994–1998The Journal of Infectious Diseases, 2002
- Permanent Declines in Pulmonary Function Following Pneumonia in Human Immunodeficiency Virus-Infected PersonsAmerican Journal of Respiratory and Critical Care Medicine, 2000